Potassium Iodide Tablets USP, 65 mg
Natural health product licensed in Canada
- Other names
- Art Pharma KI Solution Tablets USP, 65 mg, KI Solution Tablets USP, 65 mg
- Licence holder
- Art Pharmaceutical Ltd.
- NPN or DIN-HM
- 80079297
- Status
- Active licence
- Licence date
- 31 July 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Iode Source : Iodure de potassium | 50 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Nourrissons | maximum: 1 month | 0.25 Comprimé | 1 Tous les jours |
| Adultes et adolescents | minimum: 12 years | 2 Comprimé | 1 Tous les jours |
| Enfants | minimum: 3 years ; maximum: 12 years | 1 Comprimé | 1 Tous les jours |
| Nourrissons | minimum: 1 month ; maximum: 36 months | 0.5 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Thyroid blocking agent to prevent uptake of inhaled radioactive iodine by thyroid gland in a nuclear emergency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Take potassium iodide (KI) only when public officials tell you. In a nuclear radiation emergency, radioactive iodine could be released into the air. KI protects only the thyroid gland from uptake of radioactive iodine. Therefore, KI should be used along with other emergency measures that will be recommended to you by public officials, such as taking shelter indoors, evacuating or relocating from the affected area or avoiding contaminated foods or food products. If you are told to take this medicine, take it only once in a 24 hour period. Do not take it more often or at higher dose than directed by a health care authority. More will not help you and may increase the risk of serious side effects. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breastfeeding, for baby under 1 month of age or if you have thyroid disease (except nodular thyroid disease with heart disease), take as directed above and contact a doctor as soon as possible. Ensure that thyroid functions are checked by a health care practitioner in babies less than 1 month of age that take KI. Women who are pregnant or breastfeeding and patient with thyroid disease other than nodular thyroid disease with heart disease should also be checked by a doctor if repeat dosing is necessary. This product is not intended for nutritional use. Some people may experience sialadenitis (an inflammation of the salivary glands), gastrointestinal disturbance or temporary rash. If symptoms persist or worsen, consult a health care practitioner. Breastfed infants should receive their dose of KI by direct administration and should not rely on a protective effect from breast milk. Consult a health care practitioner prior to use if you have Grave's disease or autoimmune thyroiditis. Serious risks may be associated wit the repeated use of this product. Repeated doses should be supervised by a health care practitioner. This product is not intended for use as a generic anti-radiation drug. It is only effective for specific use during radioiodine exposure.
- Contre-indications
Do not use if you are allergic to iodine. Do not use if you have nodular thyroid disease with heart disease. Do not use if you have hypocomplementemic vasculitis. Do not use if you have dermatitis herpetiformis. Do not use if you have iodine sensitivity, or past or present history of hyperthyroidism.
- Effets indésirables connus
If you have swelling of the hands or feet, fever or joint pain, discontinue use and call a doctor. Discontinue use and get medical help right away if you have an allergic reaction, trouble breathing, speaking or swallowing; shortness of breath; wheezing; swelling of the mouth, tongue or throat; or rash, or in case of irregular heartbeat or chest pain.
Source
Official Health Canada record, licence 80079297
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.